- Second U.S. sailor's remains found in Afghanistan
- WRAPUP 2-BP lawsuits over oil spill take center stage
- Schwarzenegger declares California fiscal emergency
- Bear kills man, injures two near Yellowstone Park
- Key parts of Arizona anti-immigration law blocked | Video
- Four killed in Air Force plane crash in Alaska
- Obama seeks his "mojo" on daytime TV's "The View"
- Heavy rains delay salvage of crashed Pakistan plane
- China urges change in U.S. policy to avoid friction
- Foreclosures up in 75 percent of top U.S. metro areas
UPDATE 4-Cell Therapeutics drug draws US FDA staff concerns
* FDA staff raise issues with safety, effectiveness
* Pixantrone to be reviewed by advisory panel Wednesday
* Company says drug works, side effects manageable
* Shares fall nearly 40 pct (Updates shares, adds details on Novartis option)
